Clinical Trial

QLC5513 Alone or in Combination With QL1706 in Previously Treated Advanced or Metastatic TNBC.

Name: QLC5513 Alone or in Combination With QL1706 in Previously Treated Advanced or Metastatic TNBC. — clinical trial record (NCT07509515)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The study will evaluate the safety and efficacy of QLC5513 alone or in combination with QL1706 in patients with advanced or metastatic triple-negative breast cancer (TNBC) who had received ≥1 line of prior systematic therapy.

Trial Details

NCT Number	NCT07509515
Lead Sponsor	Fudan University
Conditions	Triple-negative Breast Cancer (TNBC)
Enrollment	60 participants
Start Date	2026-04-15
Primary Completion	2027-09-30 (estimated)
Study Completion	2028-03-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-03